Eli Lilly China — Revenue increased by 46.4% to $693.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 53.7%, from $451.00M to $693.00M. Over 4 years (FY 2021 to FY 2025), China — Revenue shows an upward trend with a 4.1% CAGR.
lly_segment_cn_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $522.50M | $400.30M | $376.40M | $406.50M | $352.10M | $343.40M | $350.80M | $372.70M | $399.00M | $390.80M | $377.40M | $376.20M | $395.10M | $459.90M | $428.80M | $451.00M | $465.90M | $560.40M | $473.20M | $693.00M |
| QoQ Change | — | -23.4% | -6.0% | +8.0% | -13.4% | -2.5% | +2.2% | +6.2% | +7.1% | -2.1% | -3.4% | -0.3% | +5.0% | +16.4% | -6.8% | +5.2% | +3.3% | +20.3% | -15.6% | +46.4% |
| YoY Change | — | — | — | — | -32.6% | -14.2% | -6.8% | -8.3% | +13.3% | +13.8% | +7.6% | +0.9% | -1.0% | +17.7% | +13.6% | +19.9% | +17.9% | +21.9% | +10.4% | +53.7% |